Organización Sanitaria Integrada Ezkerraldea-Enkarterri-Cruces
Organización de Osakidetza
University of Alberta
Edmonton, CanadáPublications en collaboration avec des chercheurs de University of Alberta (16)
2024
-
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
Blood, Vol. 144, Núm. 11, pp. 1193-1205
-
Features Associated With Radiographic Pneumonia in Children with SARS-CoV-2
Journal of the Pediatric Infectious Diseases Society, Vol. 13, Núm. 4, pp. 257-259
2023
-
Impact of SARS-CoV-2 Infection on the Association Between Laboratory Tests and Severe Outcomes Among Hospitalized Children
Open Forum Infectious Diseases, Vol. 10, Núm. 10
2022
-
Outcomes of SARS-CoV-2–Positive Youths Tested in Emergency Departments The Global PERN–COVID-19 Study
JAMA Network Open, Vol. 5, Núm. 1, pp. E2142322
-
Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection
JAMA Network Open, Vol. 5, Núm. 7, pp. E2223253
2021
-
Exposure and confidence across critical airway procedures in pediatric emergency medicine: An international survey study
American Journal of Emergency Medicine, Vol. 42, pp. 70-77
2019
-
Preferred learning modalities and practice for critical skills: A global survey of paediatric emergency medicine clinicians
Emergency Medicine Journal, Vol. 36, Núm. 5, pp. 273-280
2017
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
The Lancet, Vol. 390, Núm. 10091, pp. 231-266
-
Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial)
Infectious Diseases, Vol. 49, Núm. 3, pp. 200-207
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
-
Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study
Pediatric Blood and Cancer, Vol. 62, Núm. 12, pp. 2162-2166
2014
-
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Nature Genetics, Vol. 46, Núm. 9, pp. 989-993
2012
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196